Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
Type
Guidance (16)
NICE advice (2)
Quality standard (1)
Guidance programme
Guidance programme
Diagnostics guidance (2)
Highly specialised technologies guidance (1)
Interventional procedures guidance (2)
Technology appraisal guidance (11)
Advice programme
Advice programme
Medtech innovation briefings (2)
Apply filters
Showing 1 to 19 of 19
Sort by
Date
Title
Apply sorting
Last updated date between 1/2/2022 and 28/2/2022
Remove Last updated date between 1/2/2022 and 28/2/2022 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
DG45
23 February 2022
23 February 2022
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules
DG46
23 February 2022
23 February 2022
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies
TA772
23 February 2022
23 February 2022
Odevixibat for treating progressive familial intrahepatic cholestasis
HST17
22 February 2022
22 February 2022
The Insides System for managing intestinal failure
MIB286
17 February 2022
17 February 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
TA770
9 February 2022
9 February 2022
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)
TA771
9 February 2022
9 February 2022
d-Nav insulin management app for type 2 diabetes
MIB285
8 February 2022
8 February 2022
Stereotactic radiosurgery for trigeminal neuralgia
IPG715
2 February 2022
2 February 2022
Microwave ablation for primary or metastatic cancer in the lung
IPG716
2 February 2022
2 February 2022
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)
TA762
2 February 2022
2 February 2022
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable
TA763
2 February 2022
2 February 2022
Fremanezumab for preventing migraine
TA764
2 February 2022
2 February 2022
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA765
2 February 2022
2 February 2022
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
TA766
2 February 2022
2 February 2022
Ponesimod for treating relapsing–remitting multiple sclerosis
TA767
2 February 2022
2 February 2022
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs
TA768
2 February 2022
2 February 2022
Palforzia for treating peanut allergy in children and young people
TA769
2 February 2022
2 February 2022
Colorectal cancer
QS20
13 August 2012
1 February 2022
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top